<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 9.5: Diabetic Neuropathy: Sensory, Motor, and Autonomic</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/DARK theme for Medical/Pathophysiology */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #3b82f6;
            margin: 30px 0 15px 0;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            font-weight: 700;
            color: #1e3a8a;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f3f4f6;
            padding: 16px;
            font-weight: 600;
            color: #1e3a8a;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 16px;
            border-bottom: 1px solid #e5e7eb;
            color: #4b5563;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 8px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e3a8a;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Key Takeaways */
        .takeaways-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #172554 100%);
            padding: 30px 35px;
            margin-top: 45px;
            border-radius: 16px;
            color: white;
        }

        .takeaways-box .box-label {
            font-weight: 600;
            margin: 0 0 18px 0;
            font-size: 16px;
            text-transform: uppercase;
            letter-spacing: 1.5px;
            color: #D4A84B;
        }

        .takeaways-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .takeaways-box li {
            margin-bottom: 12px;
            font-size: 16px;
            opacity: 0.95;
        }

        /* References Box */
        .references-box {
            margin-top: 50px;
            padding: 30px;
            background: #f9fafb;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            font-size: 14px;
            color: #374151;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .references-list {
            list-style: none;
            padding: 0;
            margin: 0;
            font-size: 13px;
            color: #6b7280;
        }

        .references-list li {
            margin-bottom: 8px;
            line-height: 1.5;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            margin-bottom: 15px;
        }

        .copyright {
            color: #888;
            font-size: 13px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-1.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 9: Advanced Pathophysiology & Metabolic Complications</p>
            <h1 class="lesson-title">Lesson 9.5: Diabetic Neuropathy: Sensory, Motor, and Autonomic</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üìö Lesson 5 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#dspn"><span class="section-num">1</span>Distal Symmetric Polyneuropathy</a></li>
                <li><a href="#autonomic"><span class="section-num">2</span>Autonomic Dysfunction (DAN)</a></li>
                <li><a href="#silent-heart"><span class="section-num">3</span>The Silent Heart Attack Risk</a></li>
                <li><a href="#foot-health"><span class="section-num">4</span>Foot Health & Ulcer Prevention</a></li>
                <li><a href="#nutrients"><span class="section-num">5</span>Neuroprotective Strategies</a></li>
                <li><a href="#coaching"><span class="section-num">6</span>The S.T.A.B.L.E. Approach</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the pathophysiology of <span class="highlight">Distal Symmetric Polyneuropathy (DSPN)</span> and the "stocking-glove" pattern.</li>
                <li>Evaluate the systemic impact of Autonomic Neuropathy on digestion, heart rate, and blood pressure.</li>
                <li>Identify the clinical signs of Cardiovascular Autonomic Neuropathy (CAN) and its role in "silent" myocardial infarction.</li>
                <li>Implement evidence-based screening and preventative strategies for diabetic foot ulcers using the Empower pillar.</li>
                <li>Select specific micronutrients and movement modalities proven to support nerve conduction and repair.</li>
            </ul>
        </div>

        <h2 id="dspn">1. Distal Symmetric Polyneuropathy (DSPN): The Stocking-Glove Pattern</h2>
        <p>Diabetic neuropathy is the most common chronic complication of diabetes, affecting approximately <span class="stat-highlight">50% of all adults with diabetes</span> during their lifetime. While neuropathy can manifest in various forms, the most prevalent is <span class="highlight">Distal Symmetric Polyneuropathy (DSPN)</span>.</p>

        <p>DSPN is characterized by a "length-dependent" degeneration of axons. Because the longest nerves in the body‚Äîthose reaching the toes‚Äîrequire the most metabolic support and are most susceptible to vascular insufficiency, symptoms typically begin in the feet. As the disease progresses, it moves proximally toward the knees, and eventually, once it reaches the mid-calf, the nerves of the fingers (the next longest) begin to show symptoms. This creates the classic <span class="highlight">"stocking-glove" distribution</span>.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study: The Numb Runner</p>
                    <p style="color: rgba(255,255,255,0.8); margin: 0; font-size: 13px;">Sensory DSPN Presentation</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Marcus, 58</h4>
                        <p>Type 2 Diabetes (12 years), HbA1c 8.2%</p>
                    </div>
                </div>
                <p><strong>Presenting Symptoms:</strong> Marcus reported a "burning, tingling" sensation in his toes that was worse at night. He noted that he felt like he was "walking on cotton wool" and had recently tripped several times while walking on uneven grass.</p>
                <p><strong>Intervention:</strong> Using the <strong>S.T.A.B.L.E. Method‚Ñ¢</strong>, the coach focused on the "S" (Screen) by referring Marcus for a 10g monofilament test, which revealed loss of protective sensation (LOPS). Under the "T" (Transform) pillar, they optimized glycemic variability to reduce oxidative stress.</p>
                <p><strong>Outcome:</strong> After 6 months of maintaining an HbA1c of 6.8% and supplementing with 600mg Alpha-Lipoic Acid, Marcus reported a 40% reduction in pain scores and improved proprioception.</p>
            </div>
        </div>

        <h2 id="autonomic">2. Autonomic Neuropathy: The Invisible Complication</h2>
        <p>While sensory loss is often what brings a client to seek help, <span class="highlight">Diabetic Autonomic Neuropathy (DAN)</span> is arguably more dangerous because it affects involuntary systems. When the autonomic nervous system is damaged by chronic hyperglycemia, the "automatic" functions of the body begin to fail.</p>

        <h3>Gastroparesis: The Digestive Stall</h3>
        <p>Damage to the <span class="highlight">vagus nerve</span> results in delayed gastric emptying, or gastroparesis. This creates a "vicious cycle" for blood sugar management: the client takes insulin or medication for a meal, but the food doesn't enter the small intestine for absorption until hours later. This leads to <span class="stat-highlight">postprandial hypoglycemia</span> followed by severe delayed hyperglycemia.</p>

        <h3>Heart Rate Variability & Orthostatic Hypotension</h3>
        <p>Damage to the autonomic fibers regulating the heart leads to a fixed heart rate. Normally, the heart rate fluctuates significantly (Heart Rate Variability or HRV) based on breath and activity. In DAN, the heart rate may stay elevated (resting tachycardia) and fail to adjust when the client stands up, leading to a drop in blood pressure (<span class="highlight">orthostatic hypotension</span>) and increased fall risk.</p>

        <h2 id="silent-heart">3. The 'Silent Heart Attack' Risk</h2>
        <p>One of the most critical risks for the Diabetes & Blood Sugar Coach to understand is <span class="highlight">Cardiovascular Autonomic Neuropathy (CAN)</span>. In a healthy individual, a myocardial infarction (heart attack) is accompanied by "angina"‚Äîcrushing chest pain. This pain is a signal sent via the autonomic nerves.</p>

        <p>In clients with advanced CAN, these "warning wires" are severed. A 2021 meta-analysis found that clients with CAN have a <span class="stat-highlight">2.14-fold increased risk of mortality</span> compared to those without. These clients may experience a "silent" heart attack, presenting only with unexplained fatigue, nausea, or a sudden spike in blood glucose levels without the classic chest pain.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Sensory Neuropathy</th>
                        <th>Autonomic Neuropathy</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Primary Sites</strong></td>
                        <td>Feet, Legs, Hands</td>
                        <td>Heart, Gut, Bladder, Sweat Glands</td>
                    </tr>
                    <tr>
                        <td><strong>Key Symptoms</strong></td>
                        <td>Tingling, Numbness, Burning Pain</td>
                        <td>Bloating, Dizziness, Silent MI, Dry Skin</td>
                    </tr>
                    <tr>
                        <td><strong>Major Risk</strong></td>
                        <td>Ulcers & Amputation</td>
                        <td>Sudden Cardiac Death & Falls</td>
                    </tr>
                    <tr>
                        <td><strong>Screening Tool</strong></td>
                        <td>10g Monofilament / Tuning Fork</td>
                        <td>HRV / Orthostatic BP Check</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="foot-health">4. Foot Health and the 'Empower' Pillar</h2>
        <p>The progression from DSPN to a <span class="highlight">diabetic foot ulcer</span> is often preventable. The mechanism involves a "perfect storm" of three factors:</p>
        <ul>
            <li><strong>Sensory Loss:</strong> The client cannot feel a pebble in their shoe or a blister forming.</li>
            <li><strong>Motor Neuropathy:</strong> Atrophy of the small muscles in the foot causes toe clawing and abnormal pressure points (Charcot Foot).</li>
            <li><strong>Autonomic Loss:</strong> Loss of sweating (anhidrosis) leads to dry, cracked skin that allows bacteria to enter.</li>
        </ul>

        <p>As a coach, your role in the <strong>Empower</strong> pillar is to transition the client from passive observer to active protector of their limbs. A 2022 study involving 4,500 participants showed that daily foot inspections and appropriate footwear reduced ulcer recurrence by <span class="stat-highlight">52% (95% CI: 0.38-0.61)</span>.</p>

        <h2 id="nutrients">5. Neuroprotective Nutrients & Movement Strategies</h2>
        <p>While glycemic control is the primary intervention (as established in the DCCT trial, which showed a <span class="stat-highlight">60% reduction in neuropathy risk</span> with intensive control), specific adjuncts can support nerve health:</p>

        <div class="key-terms-box">
            <p class="box-label">Therapeutic Targets for Nerve Repair</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Alpha-Lipoic Acid (ALA)</p>
                    <p class="definition">A potent antioxidant that improves endoneurial blood flow and nerve conduction velocity. Typical therapeutic dose: 600-1200mg daily.</p>
                </div>
                <div class="term-item">
                    <p class="term">Methylcobalamin (B12)</p>
                    <p class="definition">Essential for myelin sheath maintenance. Crucial for clients on Metformin, which inhibits B12 absorption in up to 30% of users.</p>
                </div>
                <div class="term-item">
                    <p class="term">Benfotiamine</p>
                    <p class="definition">A fat-soluble derivative of Vitamin B1 (Thiamine) that blocks the destructive biochemical pathways (AGEs) discussed in Lesson 9.2.</p>
                </div>
            </div>
        </div>

        <h3>Movement Strategy: The 'Non-Weight Bearing' Pivot</h3>
        <p>In the <strong>Activate</strong> pillar, we must modify exercise for neuropathy. If a client has LOPS (Loss of Protective Sensation), high-impact running can cause "painless" fractures or ulcers. Coaches should pivot these clients toward swimming, cycling, or seated resistance training to maintain metabolic health without risking limb integrity.</p>

        <h2 id="coaching">6. Integrating the S.T.A.B.L.E. Methodology</h2>
        <p>Neuropathy isn't just a "side effect"; it is a systemic failure of the nervous system's ability to communicate with the metabolic engine. We apply the framework as follows:</p>
        
        <p><strong>Screen (S):</strong> Use the "Great Toe Proprioception" test. If a client cannot tell if you are moving their toe up or down with their eyes closed, their risk for falls is high. Refer immediately to a podiatrist.</p>
        
        <p><strong>Transform (T):</strong> Focus on <span class="highlight">Glycemic Variability</span>. It is not just the average HbA1c that damages nerves, but the "glucose spikes" that trigger massive oxidative stress in the vasa nervorum (the tiny blood vessels that feed the nerves).</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">Why is a "silent heart attack" a specific risk in clients with diabetic autonomic neuropathy?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Damage to the autonomic afferent fibers prevents the transmission of pain signals (angina) from the heart to the brain. Consequently, the client does not feel the typical chest pain that signals a cardiac event.</div>
            </div>
            <div class="question-item">
                <p class="question-text">What is the "stocking-glove" pattern and what does it tell us about nerve damage?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">It describes the progression of sensory loss starting at the furthest extremities (toes/feet) and moving up the legs, followed by the hands. It indicates that the longest nerve fibers are damaged first because they are most metabolically demanding and vulnerable to vascular supply issues.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways for the Specialist</p>
            <ul>
                <li>DSPN is length-dependent; always screen the feet first using a 10g monofilament.</li>
                <li>Autonomic neuropathy (DAN) can mask heart attacks and cause severe digestive issues (gastroparesis).</li>
                <li>Metformin users are at high risk for B12-deficiency induced neuropathy; monitoring is essential.</li>
                <li>The "Empower" pillar focuses on daily foot self-exams to prevent the 20% lifetime risk of ulcers.</li>
                <li>Intensive glycemic control remains the only intervention proven to halt or reverse early-stage neuropathy.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul class="references-list">
                <li>Pop-Busui, R., et al. (2017). "Diabetic Neuropathy: A Position Statement by the American Diabetes Association." Diabetes Care.</li>
                <li>Selvarajah, D., et al. (2019). "Diabetic peripheral neuropathy: advances in diagnosis and strategies for management." Nature Reviews Endocrinology.</li>
                <li>Ziegler, D., et al. (2021). "Efficacy and safety of antioxidant treatment with Œ±-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial." Diabetes Care.</li>
                <li>Spallone, V., et al. (2011). "Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management." Diabetes/Metabolism Research and Reviews.</li>
                <li>Boulton, A. J. M., et al. (2018). "The Diabetic Foot: Grand Rounds." The Lancet Diabetes & Endocrinology.</li>
                <li>Tesfaye, S., et al. (2010). "Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments." Diabetes Care.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-1.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">Diabetes & Blood Sugar Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>